from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0233/nrdB

LFCtreatmentdescriptionclass of inhibitor

-0.829

Amikacinug/mL Amikacintranslation

-0.956

Cap5-10ug/mL Capreomycintranslation

-0.984

Rox10-50 ug/mL Roxithromycintranslation

-1.033

SM2-5 ug/mL Streptomycintranslation

-2.046

Tet5-10 ug/mL Tetracyclinetranslation

0.543

Rif0.2-5ug/mL Rifampicintranscription

-0.418

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.287

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.985

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.007

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.536

Clofazimine10-13 ug/mL Clofaziminerespiration

0.662

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.966

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.140

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.066

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.986

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.762

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.857

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.564

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.289

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.130

KCN5-20 ug/mL Potassium cyaniderespiration

-0.280

NaN30.2-2 mM Sodium aziderespiration

0.146

Nigericin50 uM Nigericinrespiration

1.283

TRC10-150 ug/mL Triclosanrespiration

2.819

TRZ10-25 ug/mL Thioridazinerespiration

-0.521

Valinomycin0.5-10 uM Valinomycinrespiration

0.361

ZnSO42 mM ZnSO4respiration

0.028

menadione6-10 ug/mL Menadionerespiration

-0.453

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.266

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.065

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.471

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.349

NRP_1Non-replicating persistence stage 1dosRassociated

-0.314

Amp0.2mg/mL AmpicillincellWall

0.099

Cephalexin20-100 ug/mL CephalexincellWall

-0.625

Cerulenin0.32-5 ug/mL CerulenincellWall

0.108

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.024

EMB10-20 ug/mL EthambutolcellWall

-1.097

Eta12-40 ug/mL EthionamidecellWall

-1.225

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.311

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.223

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.461

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.305

BZA0.12 mg/mL BenzamidearomaticAmides

0.086

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.181

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.073

H2O24 mM hydrogen peroxideDNAdamaging

-0.398

Levo10 ug/mL LevofloxacinDNAdamaging

-1.093

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.612

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.548

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.665

UVUV-irradiationDNAdamaging

0.356

ARP41-4 ug/mL Antitubercular compound ARP4?

0.758

Antimycin12.5-50 ug/mL Antimycin A?

0.242

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.346

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.447

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.216

PA8240.2-2 ug/mL PA-824?

-0.612

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.354

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.823

Verapamil50 uM Verapamil?

1.081

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.776

methoxatin10-20 ug/mL Methoxatin?